
    
      The prognosis of pancreatic cancer is extremely poor even with extensive surgery,
      chemotherapy or radiation. It has been required development of new treatment modalities.
      Immunotherapy is one of the encouraging modalities for cancer patients. The investigators
      have to assess its toxicities and immune responsiveness.
    
  